TY - JOUR
T1 - Untreated hypertension and subsequent incidence of colorectal cancer
T2 - Analysis of a nationwide epidemiological database
AU - Kaneko, Hidehiro
AU - Yano, Yuichiro
AU - Itoh, Hidetaka
AU - Morita, Kojiro
AU - Kiriyama, Hiroyuki
AU - Kamon, Tatsuya
AU - Fujiu, Katsuhito
AU - Michihata, Nobuaki
AU - Jo, Taisuke
AU - Takeda, Norifumi
AU - Morita, Hiroyuki
AU - Nishiyama, Akira
AU - Node, Koichi
AU - Bakris, George
AU - Miura, Katsuyuki
AU - Muntner, Paul
AU - Viera, Anthony J.
AU - Oparil, Suzanne
AU - Lloyd-Jones, Donald M.
AU - Yasunaga, Hideo
AU - Komuro, Issei
N1 - Publisher Copyright:
© 2021, American Heart Association Inc.. All rights reserved.
PY - 2021/11/16
Y1 - 2021/11/16
N2 - BACKGROUND: Studies of the association of hypertension with incident colorectal cancer (CRC) may have been confounded by including individuals taking antihypertensive medication, at high risk for CRC (ie, colorectal polyps and inflammatory bowel disease), or with shared risk factors (eg, obesity and diabetes). We assessed whether adults with untreated hypertension are at higher risk for incident CRC compared with those with normal blood pressure (BP), and whether any association is evident among individuals without obesity or metabolic abnormalities. METHODS AND RESULTS: Analyses were conducted using a nationwide health claims database collected in the JMDC Claims Database between 2005 and 2018 (n=2 220 112; mean age, 44.1±11.0 years; 58.4% men). Participants who were taking antihypertensive medications or had a history of CRC, colorectal polyps, or inflammatory bowel disease were excluded. Each participant was categorized as having normal BP (systolic BP [SBP]<120 mm Hg and diastolic BP [DBP] <80 mm Hg, n=1 164 807), elevated BP (SBP 120–129 mm Hg and DBP <80 mm Hg, n=341 273), stage 1 hypertension (SBP 130– 139 mm Hg or DBP 80– 89 mm Hg, n=466 298), or stage 2 hypertension (SBP ≥140 mm Hg or DBP ≥90 mm Hg, n=247 734). Over a mean follow-up of 1112±854 days, 6899 incident CRC diagnoses occurred. After multivariable adjustment, compared with normal BP, hazard ratios for incident CRC were 0.93 (95% CI, 0.85–1.01) for elevated BP, 1.07 (95% CI, 0.99–1.15) for stage 1 hypertension, and 1.17 (95% CI, 1.08–1.28) for stage 2 hypertension. The hazard ratios for incident CRC for each 10-mm Hg-higher SBP or DBP were 1.04 (95% CI, 1.02–1.06) and 1.06 (95% CI, 1.03–1.09), respectively. These associations were present among adults who did not have obesity, high waist circumference, diabetes, or dyslipidemia. CONCLUSIONS: Higher SBP and DBP, and stage 2 hypertension are associated with a higher risk for incident CRC, even among those without shared risk factors for CRC. BP measurement could identify individuals at increased risk for subsequent CRC.
AB - BACKGROUND: Studies of the association of hypertension with incident colorectal cancer (CRC) may have been confounded by including individuals taking antihypertensive medication, at high risk for CRC (ie, colorectal polyps and inflammatory bowel disease), or with shared risk factors (eg, obesity and diabetes). We assessed whether adults with untreated hypertension are at higher risk for incident CRC compared with those with normal blood pressure (BP), and whether any association is evident among individuals without obesity or metabolic abnormalities. METHODS AND RESULTS: Analyses were conducted using a nationwide health claims database collected in the JMDC Claims Database between 2005 and 2018 (n=2 220 112; mean age, 44.1±11.0 years; 58.4% men). Participants who were taking antihypertensive medications or had a history of CRC, colorectal polyps, or inflammatory bowel disease were excluded. Each participant was categorized as having normal BP (systolic BP [SBP]<120 mm Hg and diastolic BP [DBP] <80 mm Hg, n=1 164 807), elevated BP (SBP 120–129 mm Hg and DBP <80 mm Hg, n=341 273), stage 1 hypertension (SBP 130– 139 mm Hg or DBP 80– 89 mm Hg, n=466 298), or stage 2 hypertension (SBP ≥140 mm Hg or DBP ≥90 mm Hg, n=247 734). Over a mean follow-up of 1112±854 days, 6899 incident CRC diagnoses occurred. After multivariable adjustment, compared with normal BP, hazard ratios for incident CRC were 0.93 (95% CI, 0.85–1.01) for elevated BP, 1.07 (95% CI, 0.99–1.15) for stage 1 hypertension, and 1.17 (95% CI, 1.08–1.28) for stage 2 hypertension. The hazard ratios for incident CRC for each 10-mm Hg-higher SBP or DBP were 1.04 (95% CI, 1.02–1.06) and 1.06 (95% CI, 1.03–1.09), respectively. These associations were present among adults who did not have obesity, high waist circumference, diabetes, or dyslipidemia. CONCLUSIONS: Higher SBP and DBP, and stage 2 hypertension are associated with a higher risk for incident CRC, even among those without shared risk factors for CRC. BP measurement could identify individuals at increased risk for subsequent CRC.
KW - Blood pressure
KW - Colorectal cancer
KW - Epidemiology
KW - Hypertension
KW - Onco-hypertension
UR - http://www.scopus.com/inward/record.url?scp=85120795965&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120795965&partnerID=8YFLogxK
U2 - 10.1161/JAHA.121.022479
DO - 10.1161/JAHA.121.022479
M3 - Article
C2 - 34724797
AN - SCOPUS:85120795965
SN - 2047-9980
VL - 10
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 22
M1 - e022479
ER -